Anthony J Weier

Array ( [id] => 4190593 [patent_doc_number] => 06130084 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-10-10 [patent_title] => 'Nutrition from pollution' [patent_app_type] => 1 [patent_app_number] => 9/374966 [patent_app_country] => US [patent_app_date] => 1999-08-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 12 [patent_no_of_words] => 2876 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 113 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/130/06130084.pdf [firstpage_image] =>[orig_patent_app_number] => 374966 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4177389 [patent_doc_number] => 06149905 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-11-21 [patent_title] => 'Tumor cells with increased immunogenicity and uses therefor' [patent_app_type] => 1 [patent_app_number] => 9/159135 [patent_app_country] => US [patent_app_date] => 1998-09-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 8 [patent_no_of_words] => 18282 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 40 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/149/06149905.pdf [firstpage_image] =>[orig_patent_app_number] => 159135 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4293170 [patent_doc_number] => 06184033 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-02-06 [patent_title] => 'Medicinal preparation based on fetal cell suspension having immune substituting effect for patients with acquired immune deficiency syndrome (HIV infection)' [patent_app_type] => 1 [patent_app_number] => 9/156258 [patent_app_country] => US [patent_app_date] => 1998-09-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 19 [patent_no_of_words] => 19044 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 146 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/184/06184033.pdf [firstpage_image] =>[orig_patent_app_number] => 156258 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4077009 [patent_doc_number] => 06054116 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-04-25 [patent_title] => 'Chimeric mouse for human and mouse immune systems' [patent_app_type] => 1 [patent_app_number] => 9/115424 [patent_app_country] => US [patent_app_date] => 1998-07-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 14 [patent_no_of_words] => 5150 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 91 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/054/06054116.pdf [firstpage_image] =>[orig_patent_app_number] => 115424 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4150912 [patent_doc_number] => 06124104 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-09-26 [patent_title] => 'Chromosome 13-linked breast cancer susceptibility gene' [patent_app_type] => 1 [patent_app_number] => 9/044908 [patent_app_country] => US [patent_app_date] => 1998-03-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 11 [patent_no_of_words] => 51438 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/124/06124104.pdf [firstpage_image] =>[orig_patent_app_number] => 044908 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4128506 [patent_doc_number] => 06033857 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-03-07 [patent_title] => 'Chromosome 13-linked breast cancer susceptibility gene' [patent_app_type] => 1 [patent_app_number] => 9/044946 [patent_app_country] => US [patent_app_date] => 1998-03-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 11 [patent_no_of_words] => 51442 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 58 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/033/06033857.pdf [firstpage_image] =>[orig_patent_app_number] => 044946 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4108977 [patent_doc_number] => 06057300 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-05-02 [patent_title] => 'Methods for treating cancers and restenosis with p21' [patent_app_type] => 1 [patent_app_number] => 9/031572 [patent_app_country] => US [patent_app_date] => 1998-02-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 12 [patent_no_of_words] => 6020 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 122 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/057/06057300.pdf [firstpage_image] =>[orig_patent_app_number] => 031572 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4089809 [patent_doc_number] => 06096305 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-08-01 [patent_title] => 'Receptor that binds IL-17' [patent_app_type] => 1 [patent_app_number] => 9/022253 [patent_app_country] => US [patent_app_date] => 1998-02-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18105 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 111 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/096/06096305.pdf [firstpage_image] =>[orig_patent_app_number] => 022253 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4220474 [patent_doc_number] => 06087556 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-07-11 [patent_title] => 'Transgenic animals capable of replicating hepatitis viruses and mimicking chronic hepatitis infection in humans' [patent_app_type] => 1 [patent_app_number] => 9/003200 [patent_app_country] => US [patent_app_date] => 1998-01-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4944 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 64 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/087/06087556.pdf [firstpage_image] =>[orig_patent_app_number] => 003200 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4151149 [patent_doc_number] => 06156307 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-12-05 [patent_title] => 'Immortalization of dendritic cells with v-myc oncogene' [patent_app_type] => 1 [patent_app_number] => 9/002380 [patent_app_country] => US [patent_app_date] => 1998-01-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 18 [patent_no_of_words] => 8077 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/156/06156307.pdf [firstpage_image] =>[orig_patent_app_number] => 002380 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4118421 [patent_doc_number] => 06071893 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-06-06 [patent_title] => 'Interleukin-12 as an adjuvant for paramyxoviridae vaccines' [patent_app_type] => 1 [patent_app_number] => 8/980160 [patent_app_country] => US [patent_app_date] => 1997-11-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 2 [patent_no_of_words] => 6439 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 65 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/071/06071893.pdf [firstpage_image] =>[orig_patent_app_number] => 980160 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4182294 [patent_doc_number] => 06037520 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-03-14 [patent_title] => 'Human breast carcinoma cell line capable of production of a spontaneously metastasizing tumor in animals for use in anticancer drug testing' [patent_app_type] => 1 [patent_app_number] => 8/958167 [patent_app_country] => US [patent_app_date] => 1997-10-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2710 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 146 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/037/06037520.pdf [firstpage_image] =>[orig_patent_app_number] => 958167 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4171275 [patent_doc_number] => 06083719 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-07-04 [patent_title] => 'Cytidine deaminase cDNA as a positive selectable marker for gene transfer, gene therapy and protein synthesis' [patent_app_type] => 1 [patent_app_number] => 8/968768 [patent_app_country] => US [patent_app_date] => 1997-10-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 8944 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/083/06083719.pdf [firstpage_image] =>[orig_patent_app_number] => 968768 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4240499 [patent_doc_number] => 06136306 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-10-24 [patent_title] => 'Method for treating tumors' [patent_app_type] => 1 [patent_app_number] => 8/943953 [patent_app_country] => US [patent_app_date] => 1997-10-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 6488 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 87 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/136/06136306.pdf [firstpage_image] =>[orig_patent_app_number] => 943953 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4140940 [patent_doc_number] => 06063359 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-05-16 [patent_title] => 'Method for determining oncogenic activity of a substance' [patent_app_type] => 1 [patent_app_number] => 8/938295 [patent_app_country] => US [patent_app_date] => 1997-09-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 9535 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 84 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/063/06063359.pdf [firstpage_image] =>[orig_patent_app_number] => 938295 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4126532 [patent_doc_number] => 06127332 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-10-03 [patent_title] => 'Muteins of IFN-.beta.' [patent_app_type] => 1 [patent_app_number] => 8/912768 [patent_app_country] => US [patent_app_date] => 1997-08-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 9 [patent_no_of_words] => 9510 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/127/06127332.pdf [firstpage_image] =>[orig_patent_app_number] => 912768 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4288068 [patent_doc_number] => 06211160 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-04-03 [patent_title] => 'Method for tolerizing a mammalian patient to administration of gene therapy virus vectors' [patent_app_type] => 1 [patent_app_number] => 8/889930 [patent_app_country] => US [patent_app_date] => 1997-07-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 11 [patent_no_of_words] => 4795 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 127 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/211/06211160.pdf [firstpage_image] =>[orig_patent_app_number] => 889930 [rel_patent_id] =>[rel_patent_doc_number] =>)